1. Home
  2. JSPRW vs PRA Comparison

JSPRW vs PRA Comparison

Compare JSPRW & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPRW
  • PRA
  • Stock Information
  • Founded
  • JSPRW N/A
  • PRA 1976
  • Country
  • JSPRW United States
  • PRA United States
  • Employees
  • JSPRW N/A
  • PRA N/A
  • Industry
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • PRA Property-Casualty Insurers
  • Sector
  • JSPRW Health Care
  • PRA Finance
  • Exchange
  • JSPRW Nasdaq
  • PRA Nasdaq
  • Market Cap
  • JSPRW N/A
  • PRA N/A
  • IPO Year
  • JSPRW N/A
  • PRA N/A
  • Fundamental
  • Price
  • JSPRW $0.12
  • PRA $13.99
  • Analyst Decision
  • JSPRW
  • PRA Buy
  • Analyst Count
  • JSPRW 0
  • PRA 3
  • Target Price
  • JSPRW N/A
  • PRA $17.67
  • AVG Volume (30 Days)
  • JSPRW 7.8K
  • PRA 169.7K
  • Earning Date
  • JSPRW 03-05-2025
  • PRA 02-24-2025
  • Dividend Yield
  • JSPRW N/A
  • PRA N/A
  • EPS Growth
  • JSPRW N/A
  • PRA N/A
  • EPS
  • JSPRW N/A
  • PRA 0.84
  • Revenue
  • JSPRW N/A
  • PRA $1,162,157,000.00
  • Revenue This Year
  • JSPRW N/A
  • PRA N/A
  • Revenue Next Year
  • JSPRW N/A
  • PRA $0.56
  • P/E Ratio
  • JSPRW N/A
  • PRA $16.67
  • Revenue Growth
  • JSPRW N/A
  • PRA 2.62
  • 52 Week Low
  • JSPRW $0.15
  • PRA $10.76
  • 52 Week High
  • JSPRW $0.16
  • PRA $17.79
  • Technical
  • Relative Strength Index (RSI)
  • JSPRW N/A
  • PRA 34.13
  • Support Level
  • JSPRW N/A
  • PRA $14.12
  • Resistance Level
  • JSPRW N/A
  • PRA $14.79
  • Average True Range (ATR)
  • JSPRW 0.00
  • PRA 0.34
  • MACD
  • JSPRW 0.00
  • PRA -0.04
  • Stochastic Oscillator
  • JSPRW 0.00
  • PRA 2.22

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: